Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FBRSL1 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
mRNA | BTN1A1 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
mRNA | UTP4 | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
mRNA | PLEKHN1 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
mRNA | SNTB2 | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
mRNA | IDH2 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
mRNA | PCDHA7 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
mRNA | SHPRH | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
mRNA | ICA1L | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
mRNA | MEGF9 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |